Cefdinir versus amoxicillin clavulanic acid in the treatment of suppurative acute otitis media in children

被引:13
作者
Adler, M
McDonald, PJ
Trostmann, U
Keyserling, C
Tack, K
机构
[1] BELMONT HLTH CTR,HARROW HA3 7LT,MIDDX,ENGLAND
[2] FLINDERS UNIV S AUSTRALIA,DEPT CLIN MICROBIOL,BEDFORD PK,SA 5042,AUSTRALIA
[3] PARKE DAVIS CLIN DEV,ANN ARBOR,MI 48105
关键词
D O I
10.1007/BF01709584
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
An investigator-blinded, randomized, multicenter study was conducted to compare the efficacy and safety of cefdinir and amoxicillin/clavulanate (amoxicillin/CA) in the treatment of pediatric patients with acute suppurative otitis media, Patients 6 months to 12 years of age were randomized in a 1:1:1 ratio to receive cefdinir 14 mg/kg once-daily, cefdinir 7 mg/kg b.i.d., or amoxicillin/CA 13.3 mg/kg t.i.d. Test-of-cure was determined 11 to 16 days post therapy. Of the 752 patients who entered the study, 665 (88%) completed treatment and 595 (79%) were evaluable, Response rates in the three treatment groups were similar, Overall rates of adverse events were statistically lower in the cefdinir once-daily group than in the amoxicillin/CA group. Diarrhea was the most common mon adverse event in all treatment groups, Cefdinir given either once-daily or twice-daily is a safe and effective treatment for pediatric patients with acute suppurative otitis media.
引用
收藏
页码:214 / 219
页数:6
相关论文
共 9 条
[1]   INVITRO ACTIVITY EVALUATIONS OF CEFDINIR (FK482, CI-983, AND PD134393) - A NOVEL ORALLY-ADMINISTERED CEPHALOSPORIN [J].
BRIGGS, BM ;
JONES, RN ;
ERWIN, ME ;
BARRETT, MS ;
JOHNSON, DM .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1991, 14 (05) :425-434
[2]   IN-VITRO EVALUATION OF CEFDINIR (FK482), A NEW ORAL CEPHALOSPORIN WITH ENHANCED ANTISTAPHYLOCOCCAL ACTIVITY AND BETA-LACTAMASE STABILITY [J].
COHEN, MA ;
JOANNIDES, ET ;
ROLAND, GE ;
MESERVEY, MA ;
HUBAND, MD ;
SHAPIRO, MA ;
SESNIE, JC ;
HEIFETZ, CL .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1994, 18 (01) :31-39
[3]   IMPORTANCE OF PATIENT COMPLIANCE IN EFFECTIVE ANTIMICROBIAL THERAPY [J].
HUSSAR, DA .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1987, 6 (10) :971-975
[4]   OTITIS-MEDIA [J].
KLEIN, JO .
CLINICAL INFECTIOUS DISEASES, 1994, 19 (05) :823-833
[5]  
POOLE JM, 1992, INFECT MED SE, V9, P19
[6]  
SHINOZAKI T, 1991, Japanese Journal of Antibiotics, V44, P1087
[7]   IN-VITRO ACTIVITY OF CEFDINIR (FK482) AND 10 OTHER ANTIBIOTICS AGAINST GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA ISOLATED FROM ADULT AND PEDIATRIC-PATIENTS [J].
SULTAN, T ;
BALTCH, AL ;
SMITH, RP ;
RITZ, W .
CHEMOTHERAPY, 1994, 40 (02) :80-91
[8]   THE INVITRO ACTIVITY OF CEFDINIR (FK482), A NEW ORAL CEPHALOSPORIN [J].
WISE, R ;
ANDREWS, JM ;
THORNBER, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 (02) :239-248
[9]  
1995, DRUG THERAPEUTIC B, V33, P12